Work

Stem cell therapy in stroke treatment: is it a viable option?

Year: 2013

Type: editorial

Abstract: Stroke is the fourth leading cause of mortality in the USA; every year almost 750,000 people have a new stroke [1]. Since stroke is the leading cause of adult disability [1], there is an urgent pub...

Source: Expert Review of Neurotherapeutics

DOI: 10.1586/ern.12.164

Authors: Osman Mir, Sean I Savitz

Language: English

Topic: Mesenchymal stem cell research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Howard Hughes Medical Institute, Celgene, National Institutes of Health, National Institute of Neurological Disorders and Stroke, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: G391342828, G4208793075, Cytoprotection with Autologous Mononuclear Cells for Stroke, Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients

OpenAlex ID: W2038430652

Cites: 20

Cited by: 7

Related to: 10